← All decks

Radiology

Positron Emission Tomography

Built from Fundamentals of Diagnostic Radiology

The first 25 slides of Positron Emission Tomography
The first 25 slides, exactly as they appear. The full deck has 149 content slides.

What’s inside

9 sections · 149 slides

  1. 01

    Overview

    • What this topic covers

    1 slide

  2. 02

    How PET works

    Positron decay, annihilation photons, detectors, and hybrid systems

    • What positron emission tomography detects
    • Positron-emitting radionuclides
    • Positron travel and image sharpness
    • From positron to image
    • PET cameras and coincidence detection
    • Time-of-flight PET
    • Hybrid scanners: PET/CT
    • PET/MR
    • Attenuation and its correction
    • Reading corrected and uncorrected images

    10 slides

  3. 03

    Performing and interpreting PET/CT

    Patient preparation, acquisition, and FDG biology

    • Preparing the patient for FDG PET
    • Limiting bladder activity
    • How the scan is acquired
    • Contrast and PET
    • Interpreting a PET/CT
    • FDG: the workhorse tracer
    • How FDG is trapped in cells
    • What drives FDG accumulation
    • Normal and variant FDG activity

    9 slides

  4. 04

    Normal FDG distribution

    Organ-by-organ physiologic uptake

    • Skeletal muscle uptake
    • Whole-body FDG PET biodistribution
    • Physiologic FDG uptake in muscle
    • Brain uptake
    • Physiologic FDG uptake in the brain
    • Cardiac muscle uptake
    • Physiologic FDG uptake in the heart
    • Liver and gallbladder uptake
    • Physiologic FDG uptake in the liver
    • Spleen and bone marrow uptake
    • Stomach uptake
    • Colon uptake
    • Massive physiologic colon activity
    • Metformin and bowel activity
    • Urinary tract activity
    • Normal urinary tract FDG activity
    • Uterus and ovaries
    • Corpus luteum cyst on FDG PET
    • Salivary and thyroid glands
    • Brown fat
    • Brown fat hypermetabolism

    21 slides

  5. 05

    Standard uptake values (SUV)

    Semiquantifying tracer uptake

    • What the SUV measures
    • Interpreting SUV numbers

    2 slides

  6. 06

    Oncologic PET imaging

    Staging, response, and recurrence across tumor types

    • Three core oncology indications
    • Lung cancer overview
    • Solitary pulmonary nodule (SPN)
    • Hot pulmonary nodule: incidental carcinoma
    • Warm pulmonary nodule: bronchoalveolar carcinoma
    • SPN false results and SUV cutoff
    • Reading a solitary pulmonary nodule
    • Lung cancer staging
    • Lung cancer staging on PET/CT
    • Lung cancer recurrence and response
    • Postradiation pneumonitis
    • Lymphoma staging principles
    • Lymphoma staging
    • Lymphoma false results
    • Lymphoma initial staging
    • Splenic lymphoma
    • Lymphoma bone marrow
    • Lymphoma early treatment response
    • Lymphoma: early treatment response
    • Lymphoma posttherapy residual mass
    • Lymphoma recurrence
    • Melanoma
    • Melanoma recurrence
    • Esophageal cancer
    • Esophageal recurrence
    • Gastric cancer
    • Pancreatic cancer
    • Colorectal cancer staging
    • Colon cancer staging
    • Colorectal false positives and technique
    • Colorectal nodes and liver
    • Hepatic metastasis from colon cancer
    • Colorectal recurrence
    • Colon anastomosis activity
    • Hepatocellular carcinoma
    • Cholangiocarcinoma
    • Hepatic metastases
    • Necrotic hepatic metastasis
    • Gallbladder cancer
    • Cholecystitis on PET/CT
    • Breast cancer on PET
    • Breast cancer on PET/CT
    • Breast cancer limits and sentinel nodes
    • Lactational breast uptake
    • Breast PET technique
    • Axillary node metastasis in breast cancer
    • Internal mammary node metastases
    • Breast pitfalls
    • Cervical cancer
    • Uterine cancer
    • Uterine cancer recurrence
    • Ovarian cancer
    • Stage 1 ovarian cancer
    • Renal and bladder malignancies
    • Transitional cell carcinoma of the bladder
    • Adrenal lesions
    • Adrenal metastasis
    • Benign adrenal adenoma
    • Testicular cancer
    • Prostate cancer
    • Head and neck cancers
    • Squamous cell carcinoma of the tongue
    • Head and neck challenges
    • Metastatic nasopharyngeal carcinoma: axial views
    • Metastatic nasopharyngeal carcinoma: coronal views
    • Sarcomas and osseous malignancies
    • Facet joint inflammation, not metastasis
    • Bone marrow stimulation versus metastases
    • Benign hypermetabolic bone marrow
    • Diffuse metastases with hypermetabolic marrow
    • Hot and cold osseous metastases
    • Hot and cold osseous metastases
    • FDG-avid osseous metastasis
    • Neuroendocrine tumors
    • Somatostatin receptor avid metastases

    75 slides

  7. 07

    Infection and inflammation

    Fever of unknown origin and sarcoidosis

    • PET in inflammation and infection
    • Fever of unknown origin (FUO)
    • Sarcoidosis
    • Cardiac sarcoidosis

    4 slides

  8. 08

    Pitfalls in PET/CT

    Physiologic, inflammatory, and technical traps

    • The core pitfall: physiologic activity
    • Brown fat revisited
    • Inflammatory processes
    • Shoulder arthritis
    • Immunotherapy-related activity
    • Immunotherapy-associated colitis
    • Benign tumors and recent surgery
    • Fractures
    • Rib fracture on PET/CT
    • Low-uptake malignancies
    • Attenuation-correction artifacts
    • Misregistration
    • CT truncation and injection leakage
    • Thymic rebound
    • Thymic rebound
    • Osteophytes and medications

    16 slides

  9. 09

    Emerging tracers

    Beyond FDG: fluciclovine and PSMA

    • Limits of FDG
    • Fluciclovine (FACBC)
    • F-18 fluciclovine PET/CT
    • PSMA PET
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Brant and Helms' Fundamentals of Diagnostic Radiology

    11 slides